Fetal serum beta2-microglobulin before and after bladder shunting: a 2-step approach to evaluate fetuses with lower urinary tract obstruction
- PMID: 17945303
- DOI: 10.1016/j.juro.2007.08.052
Fetal serum beta2-microglobulin before and after bladder shunting: a 2-step approach to evaluate fetuses with lower urinary tract obstruction
Abstract
Purpose: The evaluation of renal function in fetuses with lower urinary tract obstruction by analysis of electrolytes and beta2-microglobulin in fetal urine has limitations. We measured fetal serum beta2-microglobulin before and after bladder shunting to evaluate renal function.
Materials and methods: A total of 12 fetuses with lower urinary tract obstruction underwent vesicoamniotic shunting. In addition to the standard evaluation of urinary electrolytes and beta2-microglobulin, fetal renal status was assessed by pre-shunt and post-shunt fetal serum beta2-microglobulin.
Results: At 2 to 4 weeks after shunting 2 of the 12 fetuses had persistent oligohydramnios, demonstrated increased values of serum beta2-microglobulin and were confirmed to have renal dysplasia. In the remaining 10 fetuses there was reaccumulation of amniotic fluid for a minimum of 4 weeks after shunting. Serum beta2-microglobulin values increased after shunting in 4 fetuses, all of which developed renal failure, whereas serum beta2-microglobulin did not change or was decreased after shunting in 6, of which 4 had normal renal function at latest followup.
Conclusions: Urinary electrolytes, urinary beta2-microglobulin and pre-shunt serum beta2-microglobulin, whether increased or normal, failed to be predictive of potential response to prenatal intervention. Serial samples of fetal blood may provide distinction between patients who do and do not respond to prenatal treatment of lower urinary tract obstruction.
Similar articles
-
Outcome analysis of vesicoamniotic shunting in a comprehensive population.J Urol. 2001 Sep;166(3):1036-40. J Urol. 2001. PMID: 11490292
-
Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction.Obstet Gynecol. 2005 Sep;106(3):503-8. doi: 10.1097/01.AOG.0000171117.38929.eb. Obstet Gynecol. 2005. PMID: 16135579
-
PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial.BJOG. 2007 Jul;114(7):904-5, e1-4. doi: 10.1111/j.1471-0528.2007.01382.x. BJOG. 2007. PMID: 17567421 Clinical Trial.
-
Fetal lower urinary tract obstruction.Clin Perinatol. 2009 Jun;36(2):377-90, x. doi: 10.1016/j.clp.2009.03.010. Clin Perinatol. 2009. PMID: 19559326 Review.
-
[Prognosis of prenatal uropathies: should fetal urine tests be continued?].J Gynecol Obstet Biol Reprod (Paris). 1996;25(5):510-4. J Gynecol Obstet Biol Reprod (Paris). 1996. PMID: 8926354 Review. French.
Cited by
-
Fetal Lower Urinary Tract Obstruction (LUTO): a practical review for providers.Matern Health Neonatol Perinatol. 2015 Nov 18;1:26. doi: 10.1186/s40748-015-0026-1. eCollection 2015. Matern Health Neonatol Perinatol. 2015. PMID: 27057343 Free PMC article. Review.
-
Severe antenatally diagnosed renal disorders: background, prognosis and practical approach.Pediatr Nephrol. 2016 Apr;31(4):563-74. doi: 10.1007/s00467-015-3140-4. Epub 2015 Jun 17. Pediatr Nephrol. 2016. PMID: 26081158 Review.
-
Antenatal Determinants of Postnatal Renal Function in Fetal Megacystis: A Systematic Review.Diagnostics (Basel). 2024 Apr 2;14(7):756. doi: 10.3390/diagnostics14070756. Diagnostics (Basel). 2024. PMID: 38611669 Free PMC article. Review.
-
Minimally invasive fetoscopic interventions: an overview in 2010.Surg Endosc. 2010 Aug;24(8):2056-67. doi: 10.1007/s00464-010-0879-3. Epub 2010 Mar 17. Surg Endosc. 2010. PMID: 20237804
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical